1、Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia I N S I G H T R E P O R TM A Y 2 0 2 5In collaboration with Centre for Impact Investing and Practices and Philanthropy Asia AllianceImages:Getty ImagesDisclaimer This document is published by the World Economic Forum as

2、 a contribution to a project,insight area or interaction.The findings,interpretations and conclusions expressed herein are a result of a collaborative process facilitated and endorsed by the World Economic Forum but whose results do not necessarily represent the views of the World Economic Forum,nor

3、 the entirety of its Members,Partners or other stakeholders.2025 World Economic Forum.All rights reserved.No part of this publication may be reproduced or transmitted in any form or by any means,including photocopying and recording,or by any information storage and retrieval system.ContentsForeword

4、3Executive summary 41 The global threat of antimicrobial resistance 51.1 The scale of the crisis 51.2 The background 51.3 Not just a health issue 71.4 Market failures and economic impact 81.5 The impact of climate change 81.6 The global response 92 Asia:The perfect crucible for AMR 112.1 The scale o

5、f the problem 112.2 Asias rapidly changing demographics 132.3 The factors influencing AMR in Asia 152.4 An urgent call to action 193 Supercharging the fight against superbugs 203.1 Opportunities ripe for capitalizing 20Conclusion 40Contributors 41Endnotes 432Targeted Action and Financing the Fight A

6、gainst Antimicrobial Resistance in AsiaTargeted Action and Financing the Fight Against Antimicrobial Resistance in AsiaMay 2025Mobilizing the financial resources required to reduce deaths associated with antimicrobial resistance(AMR)around the world could save more than 100million lives by 2050.In a